Reply

Affiliations

¹ University of Alabama at Birmingham.
² Toronto Western Hospital, Mount Sinai Hospital and University of Toronto, Toronto, Ontario, Canada.
³ VA Medical Center, MetroHealth Medical Center and Case Western Reserve, Cleveland, OH.
⁴ VA North Texas Health Care System and University of Texas Southwestern Medical Center, Dallas, TX.
⁵ Brigham and Women's Hospital, Boston, MA.
⁶ Hospital for Special Surgery and Weill Cornell Medicine, New York, NY.
⁷ Cleveland Clinic Foundation, Cleveland, OH.
⁸ Harpaz Herman Consultants, LLC, Atlanta, GA.
⁹ Centers for Disease Control and Prevention, Atlanta, GA.
¹⁰ Duke University, Durham, NC.
¹¹ American College of Rheumatology, Atlanta, GA.
¹² The Permanente Medical Group, Union City, CA.
¹³ University of Nebraska Medical Center and VA Nebraska-Western Iowa Health Care System, Omaha, NE.

Comment

Jeffrey R Curtis et al. Arthritis Rheumatol. 2021 Sep.

. 2021 Sep;73(9):1769-1770.

doi: 10.1002/art.41805. Epub 2021 Jul 16.

¹ University of Alabama at Birmingham.
² Toronto Western Hospital, Mount Sinai Hospital and University of Toronto, Toronto, Ontario, Canada.
³ VA Medical Center, MetroHealth Medical Center and Case Western Reserve, Cleveland, OH.
⁴ VA North Texas Health Care System and University of Texas Southwestern Medical Center, Dallas, TX.
⁵ Brigham and Women's Hospital, Boston, MA.
⁶ Hospital for Special Surgery and Weill Cornell Medicine, New York, NY.
⁷ Cleveland Clinic Foundation, Cleveland, OH.
⁸ Harpaz Herman Consultants, LLC, Atlanta, GA.
⁹ Centers for Disease Control and Prevention, Atlanta, GA.
¹⁰ Duke University, Durham, NC.
¹¹ American College of Rheumatology, Atlanta, GA.
¹² The Permanente Medical Group, Union City, CA.
¹³ University of Nebraska Medical Center and VA Nebraska-Western Iowa Health Care System, Omaha, NE.

No abstract available

Comment on

American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 1.
Curtis JR, Johnson SR, Anthony DD, Arasaratnam RJ, Baden LR, Bass AR, Calabrese C, Gravallese EM, Harpaz R, Sadun RE, Turner AS, Williams EA, Mikuls TR. Curtis JR, et al. Arthritis Rheumatol. 2021 Jul;73(7):1093-1107. doi: 10.1002/art.41734. Epub 2021 May 24. Arthritis Rheumatol. 2021. PMID: 33728796 Free PMC article.
Use of Tofacitinib in the Context of COVID-19 Vaccination: Comment on the American College of Rheumatology Clinical Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases.
Mortezavi M, Menon S, Lee K, Rivas J. Mortezavi M, et al. Arthritis Rheumatol. 2021 Sep;73(9):1768-1769. doi: 10.1002/art.41806. Epub 2021 Jul 29. Arthritis Rheumatol. 2021. PMID: 34042319 Free PMC article. No abstract available.

1. Winthrop KL, Curtis JR, Lindsey S, Tanaka Y, Yamaoka K, Valdez H, et al. Herpes zoster and tofacitinib: clinical outcomes and the risk of concomitant therapy. Arthritis Rheumatol 2017;69:1960–8. - PMC - PubMed
1. Bechman K, Subesinghe S, Norton S, Atzeni F, Galli M, Cope AP, et al. A systematic review and meta-analysis of infection risk with small molecule JAK inhibitors in rheumatoid arthritis. Rheumatology (Oxford) 2019;58:1755–66. - PubMed
1. Curtis JR, Xie F, Yun H, Bernatsky S, Winthrop KL. Real-world comparative risks of herpes virus infections in tofacitinib and biologic-treated patients with rheumatoid arthritis. Ann Rheum Dis 2016;75:1843–7. - PMC - PubMed
1. Calabrese LH, Abud-Mendoza C, Lindsey SM, Lee SH, Tatulych S, Takiya L, et al. Live zoster vaccine in patients with rheumatoid arthritis treated with tofacitinib with or without methotrexate, or adalimumab with methotrexate: a post hoc analysis of data from a phase IIIb/IV randomized study. Arthritis Care Res (Hoboken) 2020;72:353–9. - PMC - PubMed
1. Uhlig T, Kvien TK, Pincus T. Test-retest reliability of disease activity core set measures and indices in rheumatoid arthritis. Ann Rheum Dis 2009;68:972–5. - PubMed